support online
Hepatit C (HCV)
Sök efter namn:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Ð
  • Copegus
    $7.71
    Copegus
    Ribavirin
    Copegus is used to treat chronic hepatitis C which is a disease of the liver. It helps the ...
    KöP NU
  • Daclatasvir
    $24.93
    Daclatasvir
    Daclatasvir
    Daclatasvir is an antiviral medicine that prevents hepatitis C virus (HCV) from multiplying ...
    KöP NU
  • Daklinza
    $24.93
    Daklinza
    Daclatasvir
    Daklinza (daclatasvir) is an antiviral medicine that prevents hepatitis C virus (HCV) from ...
    KöP NU
  • Harvoni
    $15.43
    Harvoni
    Ledipasvir / Saofosbuvir
    Generic Harvoni is an antiviral medication used to treat hepatitis C (Hep C). Generic Harvoni ...
    KöP NU
  • Sofosbuvir
    $52.57
    Sofosbuvir
    Sofosbuvir
    Sofosbuvir is an antiviral medication that prevents hepatitis C virus (HCV) from multiplying ...
    KöP NU
  • Sovaldi
    $52.57
    Sovaldi
    Sofosbuvir
    Generic Sovaldi (Sofosbuvir) is an antiviral medication that prevents hepatitis C virus (HCV) ...
    KöP NU
Kundbrev
Rafale Le Roy Ladurie, Frankrike
Jag har mottagit produkten och jag ville ta detta tillfälle i akt och tacka er för er fantastiska kundservice. Ert företag har hanterat alla situationer professionellt. Tack så ...
Boris
Jag tackar för Levitran ni skickade ut. Kanonfin produkt till ett bra pris. Jag ska tipsa kompisar om eran sida och eran suveräna onlinesupport.
Nyheter
AI stethoscope could detect major heart conditions in seconds
The new technology could be a "game-changer" resulting in patients being treated sooner, experts say.
Children to be offered chickenpox vaccine on NHS
All young children in England and Wales will be offered a free chickenpox vaccine by the NHS from January 2026.
Price of Mounjaro to be discounted in UK pharmacies
The rebate allays fears of a 170% price rise but patients are warned the cost of the drug will still jump.
NHS to lose out on new drugs, pharma firm warns
The claims from pharmaceutical giant Novartis comes amid a row over drug pricing deals.